To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers

Clinical trial NCT04908462 · COMPLETED

Trial details

NCT number: NCT04908462
Sponsor: AceLink Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney

Start date: 2021-06-08
Primary completion: 2022-06-20
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.